Searchable abstracts of presentations at key conferences in endocrinology

ea0050oc5.1 | Reproduction and Neuroendocrinology | SFEBES2017

Increased sertoli cell proliferation and sperm production in FSTL3 deleted mice

Mejia Randy Ballesteros , Mukherjee Abir

Male problems such as oligospermia, azoospermia among others, affect around 30% of infertile couples. Male fecundity relies on the production of large numbers of spermatozoa which is dependent on the number of Sertoli cells. Activin and related TGFβ family ligands regulate testicular development and function. Follistatin Like-3 (FSTL3) is a glycoprotein that binds and inhibits activin. FSTL3 deletion in mice leads to increased adult testicular size with concurrent increas...

ea0050oc5.1 | Reproduction and Neuroendocrinology | SFEBES2017

Increased sertoli cell proliferation and sperm production in FSTL3 deleted mice

Mejia Randy Ballesteros , Mukherjee Abir

Male problems such as oligospermia, azoospermia among others, affect around 30% of infertile couples. Male fecundity relies on the production of large numbers of spermatozoa which is dependent on the number of Sertoli cells. Activin and related TGFβ family ligands regulate testicular development and function. Follistatin Like-3 (FSTL3) is a glycoprotein that binds and inhibits activin. FSTL3 deletion in mice leads to increased adult testicular size with concurrent increas...

ea0029p411 | Clinical case reports - Thyroid/Others | ICEECE2012

Double jeopardy in pregnancy: a case of autoimmune polyglandular syndrome type 2 in a pregnant patient

Li R. , Mejia A. , Manalo M. , Lantion-Ang F. , Tamban C.

This is a case of an adult female who presented with 1 year history of palpitations, heat intolerance, easy fatigability, hyperdefecation and proptosis. She was admitted to this institution due to 3 month history of nausea, vomiting, abdominal pain, flank pain and generalized weakness. During admission, she was diagnosed with hyperthyroidism supported by laboratory findings of suppressed thyroid stimulating hormone and elevated free thyroxine levels and was then treated with m...

ea0043oc8 | Cardiovascular Outcome Studies | WCTD2016

Bromocriptine shifts the blood pressure circadian rhythm in type 2 DM and stage 4 of chronic kidney disease patients: A post hoc study

Mejia-Rodriguez Oliva , Ruiz-Vega Humberto , Alvarez-Aguilar Cleto , Ceballos-Reyes Guillermo , Galvan-Plata Maria Eugenia , Paniagua Ramon

Background: Type 2 DM and chronic renal disease CKD are conditions associated with severe hypertension, loss of the blood pressure circadian rhythm (CR) and sympathetic nervous system (SNS) hyperactivity, suggesting a deficient dopaminergic modulation that could be reversed with dopamine agonists such as bromocriptine (BEC).Objective: The objective of this study was to evaluate the effect of bromocriptine in the blood pressure CR in patients with type 2 ...

ea0090ep81 | Adrenal and Cardiovascular Endocrinology | ECE2023

Successful management of adrenal Cushing’s syndrome associated with androgen co-secreting adenoma during pregnancy: a case report

Rodriguez Arrieta Luis Antonio , Hoyos Valdelamar Juan Carlos , Restrepo Johnayro Gutierrez , Mejia Sanjuanelo Ana Milena , Rueda Galvis Myriam Vanessa , Corrales Santander Hugo Rafael

Introduction: Adrenal Cushing’s syndrome during pregnancy is rare, and few cases have been reported. It is infrequent to identify pregnant women with adenomas that have cortisol and androgen co-secretion. The diagnosis and treatment of excess cortisol during pregnancy is challenging when the patient does not want a pregnancy interruption.Case Report: 38-year-old woman with arterial hypertension for four years. During her working days, she remained u...

ea0022p93 | Bone/Calcium | ECE2010

Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency

Mazziotti Gherardo , Porcelli Teresa , Bianchi Antonio , Cimino Vincenzo , Mejia Carola , Patelli Ilaria , Fusco Alessandra , Giampietro Antonella , De Marinis Laura , Giustina Andrea

GH deficiency (GHD) and excess of glucocorticoids are associated with increased risk of fragility fractures. Most adult GHD patients have other pituitary deficiencies, but it is unclear whether these deficiencies or their overreplacement therapies may influence the bone disease occurring in GHD. The aim of this study was to evaluate whether the prevalence of vertebral fractures may be influenced by glucocorticoid replacement therapy in hypopituitary males with GHD. We studied ...

ea0081p77 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Comparison of hyperphagia and problem behaviors in participants with prader-willi syndrome (PWS) receiving diazoxide choline extended-release (DCCR) with matched participants in PATH for PWS (PfPWS)

Gevers Evelien , Strong Theresa , Miller Jennifer , Felner Eric , Goldstone Tony , Bridges Nicola , Yanovski Jack , Bird Lynne , Butler Merlin , Obrynba Kathryn , Lah Melissa , Shoemaker Ashley , Mejia-Corletto Jorge , Stevenson David , Wilding John , Kimonis Virginia , Abuzzahab Jennifer , Konczal Laura , Mathew Verghese , Cowen Neil , Woloschak Michael , Bhatnagar Anish

Background: PWS is a rare neurodevelopmental genetic disorder characterized by hyperphagia, obesity, hormonal deficiencies, and problem behaviors for which there are no approved treatment. DCCR administration (100-525 mg/day) up to 52 weeks in participants with PWS improved hyperphagia, behavior, body composition and metabolic markers.Objective: The objective of this study was to compare changes in hyperphagia (using Hyperphagia Questionnaire for Clinica...

ea0081ep360 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Long-term safety of diazoxide choline extended-release (DCCR) tablets in patients with prader-willi syndrome

Gevers Evelien , Miller Jennifer , Butler Merlin , Bridges Nicola , Goldstone Tony , Obrynba Kathryn , Salehi Parisa , Felner Eric , Bird Lynne , Shoemaker Ashley , Konczal Laura , Lah Melissa , Yanovski Jack , Angulo Moris , Mejia-Corletto Jorge , Stevenson David , Wilding John , Abuzzahab Jennifer , Shaikh Guftar , Viskochil David , Mathew Verghese , Yen Kristen , Woloschak Michael , Bhatnagar Anish

Background: Prader-Willi syndrome (PWS), a rare genetic neurobehavioral-metabolic condition, is characterized by hyperphagia, accumulation of excess fat, hypotonia, and behavioral/psychological complications. There are no currently approved medications to treat hyperphagia in patients with PWS; DCCR is under development as a treatment for PWS.Objectives and Methods: The objective was to evaluate long-term safety of DCCR in individuals with PWS. 125 parti...